EPO Patents = 2

Forward Citations = 2

Loading Chart...

12 inventors (with patents filed for the assignee):

Runsheng Li (6 out of 16 patents)

Wentao Huang (5 out of 14 patents)

Ying Qin Zang (4 out of 4 patents)

4. Zhifang Liu (3 out of 3 patents)

5. Yifan Li (1 out of 16 patents)

6. Fang Sun (1 out of 3 patents)

7. Youni Zhan (1 out of 1 patent)

8. Wei Cao (1 out of 7 patents)

9. Wei Cao (1 out of 1 patent)

10. Wentao Huang (1 out of 1 patent)

11. Haijuan Gu (1 out of 1 patent)

12. Ying Qin Zang (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 12583925 - BISPECIFIC ANTIBODIES TARGETING PD1 AND VEGF (2026-03-24),

2. 12291537 - Compounds, compositions and methods (2025-05-06),

3. 12247081 - CEACAM5-dependent 4-1BB-agonistic bispecific antibodies (2025-03-11),

4. 12194106 - Antibodies targeting LIV-1 and uses thereof (2025-01-14),

5. 12180276 - Antibodies and antibody-drug conjugates targeting claudin 6 (2024-12-31),

6. 11873342 - Anti-CCR8 monoclonal antibodies and uses thereof (2024-01-16),

7. 10882853 - Tyrosine kinase inhibitor and application thereof (2021-01-05),

Company Overview

Lanova Medicines Limited is a pharmaceutical company dedicated to the development and commercialization of innovative therapies for various health conditions. The company specializes in research that targets unmet medical needs, focusing on areas such as chronic diseases and rare disorders. Lanova is committed to advancing drug development through state-of-the-art scientific research and collaboration with healthcare professionals. Their pipeline includes several promising candidates that are undergoing clinical trials. With a strong emphasis on quality and regulatory compliance, Lanova aims to deliver safe and effective medications to improve patient outcomes worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#348 in Shanghai

#3,923 in China

Shanghai, China

Lanova Medicines Limited

Forward Citations = 2

12 inventors:

Runsheng Li (6 out of 16 patents)

Wentao Huang (5 out of 14 patents)

Ying Qin Zang (4 out of 4 patents)

4. Zhifang Liu (3 out of 3 patents)

5. Yifan Li (1 out of 16 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lanova Medicines Limited. Retrieved from https://idiyas.com/company/lanova-medicines

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]